The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Potential Usefulness of Inflammatory Markers to Monitor Respiratory Functional Impairment in Sarcoidosis
Open accessAbstract
Background: Sarcoidosis is a multiorgan inflammatory granulomatous disorder of unknown origin for which adequate markers to monitor disease severity are lacking. The aim of this study was to evaluate the potential clinical usefulness of serologic markers of inflammation [high-sensitivity C-reactive protein (hs-CRP) and serum amyloid A (SAA)], T-cell activation [soluble interleukin-2 receptor (sIL2R)], and granuloma formation [angiotensin-converting enzyme (ACE)] for monitoring of sarcoidosis. Methods: Of the 185 sarcoidosis patients who visited the Sarcoidosis Management Center between 1999 and 2002, we selected 144 nonsmoking patients: 73 untreated (group I) and 71 treated (group II). Subgroups of the untreated patients [group Ia (nonchronic group with time since diagnosis ≤2 years) and group Ib (chronic group with time since diagnosis >2 years)] were evaluated separately. ROC curves and logistic regression analyses were used to compare the diagnostic accuracy of different markers to assess disease severity. Pulmonary disease severity was defined by lung function test results. Results: In untreated subgroup Ia and the total untreated group (group I), sIL2R had the largest areas under the curves (AUCs; 0.891 and 0.799, respectively) and the highest sensitivity (82% and 64%), specificity (94% and 88%), and positive (82% and 70%) and negative (94% and 88%) predictive values among the evaluated markers in both untreated groups. Nevertheless, the confidence intervals for sIL2R AUC, sensitivity, and specificity were broad and partly overlapped those of ACE, hs-CRP, and SAA. In the treated group (group II), all four markers appeared to have comparable AUCs, ranging from 0.645 for SAA to 0.711 for sIL2R. Conclusion: sIL2R appears to be useful for monitoring respiratory disease severity in sarcoidosis. We recommend sIL2R measurement in the follow-up of patients with sarcoidosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · cited 1×
“... stimuli generally lead to activation of monocyte-macrophages, which in turn produce cytokines, e.g., tumor necrosis factor-, and interleukins, e.g., interleukin-1 (IL1)5 and IL6 (4, 5) . As a consequence, IL1 and IL6 concentrations increase and stimulate hepatic production of acute-phase proteins such as C-reactiv…”
BackgroundThe STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Moher, D., Rennie, D., de Vet, H. C. W., & Lijmer, J. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00012-w1 · Cited by 1,124
Cited by
A Concise Review of Pulmonary Sarcoidosis
Baughman, R. P., Culver, D. A., & Judson, M. A. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0865ci · Cited by 536
JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis ― Digest Version ―
Terasaki, F., Azuma, A., Anzai, T., Ishizaka, N., Ishida, Y., Isobe, M., Inomata, T., Ishibashi-Ueda, H., Eishi, Y., Kitakaze, M., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0508 · Cited by 479
Neurosarcoidosis: a clinical dilemma
Hoitsma, E., Faber, C. G., Drent, M., & Sharma, O. P. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00805-1 · Cited by 382
Self-citationSarcoidosis-associated fatigue
Drent, M., Lower, E. E., & De Vries, J. (2012) · European Respiratory Journal · doi:10.1183/09031936.00002512 · Cited by 285
Self-citation
Metadata
- Authors
- Rothkrantz-Kos, S., van Dieijen-Visser, M. P., Mulder, P. G. H., & Drent, M.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-09-01
- Volume
- 49
- Issue
- 9
- Pages
- 1510-1517
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2046470313
- Cited by
- 172
- References
- 3
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potential Usefulness of Inflammatory Markers to Monitor Respiratory Functional Impairment in Sarcoidosis. https://app.cochat.ai/papers/10.1373/49.9.1510
- The paper
- Rothkrantz-Kos, S., van Dieijen-Visser, M. P., Mulder, P. G. H., & Drent, M. (2003). Potential Usefulness of Inflammatory Markers to Monitor Respiratory Functional Impairment in Sarcoidosis. Clinical Chemistry. https://doi.org/10.1373/49.9.1510
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.